Showing results (151-160 of 4,868) with videos related to
Sort By:
Pageof 487
Urologic Oncology|December 12, 2002
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European menMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.Urologic Oncology|December 12, 2002
Presence of circulating prostate cancer cells in African American males adversely affects survivalFernando J Bianco, Isaac J Powell, Michael L Cher, et al.Urologic Oncology|December 12, 2002
Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladderR Daniel Bonfil, Daniela M Russo, M Mercedes Binda, et al.Urologic Oncology|December 12, 2002
The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified?Adrian P M van der MeijdenUrologic Oncology|April 10, 2003
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II studyJeri Kim, Randall E Millikan, Terry L Smith, et al.Urologic Oncology|April 10, 2003
Predictors of extracapsular extension and positive margins in African American and white menEdmond L Paquette, Roger R Connelly, Leon Sun, et al.Urologic Oncology|April 10, 2003
Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomesJeffrey A Leslie, Tom Prihoda, Ian M ThompsonUrologic Oncology|April 10, 2003
Benign fibrous histiocytoma: a rare finding on bone scan staging for prostate adenocarcinomaMichael A Simon, Brian J MilesUrologic Oncology|April 10, 2003
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancerIan M Thompson, Joseph A Basler, Robin Leach, et al.Urologic Oncology|September 5, 2003
CYP17 gene promoter allelic variant is not associated with prostate cancerCheng-Chieh Lin, Hsi-Chin Wu, Wen-Chi Chen, et al.Pageof 487